跳至主要内容
临床试验/NCT00735722
NCT00735722终止不适用

A Prospective Randomized Trial Comparing Freedom From Atrial Fibrillation at One Year Post CABG in Patients Undergoing Concomitant Left Atrial Ablation Using HIFU Versus CABG in Patients With Persistent or Long Standing Persistent AF

Abbott Medical Devices19 个研究点 分布在 6 个国家目标入组 188 人开始时间: 2009年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
188
试验地点
19
主要终点
Freedom from Atrial Arrhythmias (AF, Atrial Flutter, Atrial Tachycardia) at 12 months

研究概览

简要总结

Concomitant AF ablation with HIFU in patients with persistent or long standing persistent AF undergoing CABG will be superior in restoring SR, compared with patients with persistent or long standing persistent AF undergoing CABG treated with best medical treatment according to ACC/AHA/ESC 2006 guidelines and no AF ablation.

详细描述

Primary Objective

• To compare the efficacy of concomitant AF ablation using HIFU to no ablation at 12 months in patients with persistent or long standing persistent AF undergoing CABG according to ACC/AHA/ESC 2006 guidelines and HRS/EHRA/ECAS Consensus Statement on Catheter and Surgical Ablation .

Secondary Objectives

  • To compare the safety of concomitant AF ablation using HIFU to no ablation in patients with persistent or long standing persistent AF undergoing CABG.
  • To compare AF burden in patients with persistent or long standing persistent AF treated with concomitant HIFU AF ablation undergoing CABG to those receiving no ablation.
  • To compare the quality of life of patients with persistent or long standing persistent AF treated with concomitant HIFU AF ablation undergoing CABG to those receiving no ablation.
  • To compare the health economic impact of concomitant AF ablation with HIFU in patients with persistent or long standing persistent AF undergoing CABG to those receiving no ablation.
  • To compare the morbidity associated with persistent or long standing persistent AF in patients following CABG and ablation compared to those receiving no ablation.
  • To compare cardiac function and left atrial transport associated with persistent or long standing persistent AF patients following CABG and ablation compared to those receiving no ablation.
  • To document the incidence of immediate post ablation bidirectional conduction block through the pulmonary venous cinch and mitral lines.
  • To document the effect of Intra-operative pre and post ablation stimulation and ablation of the autonomic ganglia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Legal age in host country
  • Scheduled for CABG surgery
  • Patient suffering from persistent or long-standing persistent AF
  • Patients having the ability to fully comply with the study requirements
  • Life expectancy > 2 years
  • Patients who have given written informed consent to participate in the study

排除标准

  • Clinically significant local or systemic infection or active endocarditis
  • Sutures, pacing/defibrillator leads on the left side of the heart, valve prostheses or rings, or other implanted material in or adjacent to target treatment area.
  • Stent in the coronary artery preventing an adequate mitral line
  • Any other concomitant operation on the heart
  • Previous heart surgery
  • Patients who are or may potentially be pregnant
  • Previous catheter ablation for atrial arrhythmia
  • LA size more than 60 mm in apical view on Trans-Thoracic Echocardiogram (TTE)
  • LA thrombus on intra-operative Trans-Oesophageal Echocardiogram (TOE)
  • Known contraindication to Amiodarone
  • Inability to undergo TOE
  • Patients who are unable to give full informed consent for the study.

研究组 & 干预措施

Concomitant HIFU ablation

Active Comparator

HIFU AF Ablation

干预措施: HIFU AF Ablation (Device)

Best medical treatment

No Intervention

Best medical treatment

结局指标

主要结局

Freedom from Atrial Arrhythmias (AF, Atrial Flutter, Atrial Tachycardia) at 12 months

时间窗: 12 months

次要结局

  • Quality of life measurements (SF-36)(24 months)
  • Freedom from AF and other atrial arrhythmias at 3, 6, 9 and 18 months post ablation procedure (determined by 24 hour Holter monitor)(18 months)
  • Morbidity performing concurrent ablation in patients undergoing CABG assessed using length of ICU and hospital stay(24 months)
  • Freedom from AF and other atrial arrhythmias at 24 months post ablation procedure (determined by 72 hour Holter monitor)(24 months)
  • AF burden (determined by 24 and 72 hour Holter monitor).(24 months)
  • Incidence of stroke, TIA, PV stenosis, bleeding, thromboembolic complications, subsequent pace maker implantation, and death(24 months)
  • LV function and dimensions and LA size/transport capability(24 months)
  • Incidence of conduction block post ablation both intraoperatively across the pulmonary venous and mitral lines(At intervention)
  • Effect of autonomic ganglia stimulation pre and post ablation intra-operatively(Discharge)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验